Literature DB >> 11642420

Mechanism of hearing loss in irradiated ears: a long-term longitudinal study.

Y H Young1, Y C Lu.   

Abstract

A 10-year longitudinal follow-up study of hearing was conducted in patients with nasopharyngeal carcinoma (NPC) in order to elucidate the mechanism of hearing loss in irradiated ears. Ten NPC patients were subjected to a battery of audiological tests before irradiation and 6 months, 5 years, and 10 years after irradiation. The tests included pure tone audiometry, tympanometry, eustachian tube function testing, and myringotomy to confirm middle ear effusion. The prevalences of otitis media with effusion (OME) were 25%, 25%, 40%, and 25% at the 4 testing periods described above, respectively. The prevalences of chronic otitis media were 0%, 0%, 15%, and 25%, respectively. In myringotomized ears (n = 17), the mean hearing levels for both air conduction and bone conduction were preserved from the preirradiation period to 10 years after irradiation. In contrast, in grommeted ears (n = 3), the mean hearing levels for both air conduction and bone conduction deteriorated progressively from the preirradiation period to 10 years after irradiation. We conclude that hearing can be preserved in NPC patients 10 years after irradiation if middle ear inflammation is well controlled. We do not recommend grommet insertion in irradiated NPC patients with OME, as it may result in persistent otorrhea and hearing deterioration.

Entities:  

Mesh:

Year:  2001        PMID: 11642420     DOI: 10.1177/000348940111001002

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  7 in total

1.  Challenges of Hearing Rehabilitation after Radiation and Chemotherapy.

Authors:  Marc-Elie Nader; Paul W Gidley
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-04

2.  Long-term result of management of otitis media with effusion in patients with post-irradiated nasopharyngeal carcinoma.

Authors:  Kai-Li Liang; Mao-Chang Su; Chih-Wen Twu; Rong-San Jiang; Jin-Ching Lin; Jiun-Yih Shiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-15       Impact factor: 2.503

3.  The effectiveness of myringotomy and ventilation tube insertion versus observation in post-radiation otitis media with effusion.

Authors:  Paninee Charusripan; Likhit Khattiyawittayakun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-24       Impact factor: 2.503

Review 4.  Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

Authors:  Eric J Chow; Lynnette Anderson; K Scott Baker; Smita Bhatia; Gregory M T Guilcher; Jennifer T Huang; Wendy Pelletier; Joanna L Perkins; Linda S Rivard; Tal Schechter; Ami J Shah; Karla D Wilson; Kenneth Wong; Satkiran S Grewal; Saro H Armenian; Lillian R Meacham; Daniel A Mulrooney; Sharon M Castellino
Journal:  Biol Blood Marrow Transplant       Date:  2016-01-21       Impact factor: 5.742

5.  Incidence of Otitis Media with Effusion in Cases of Head and Neck Malignancies Undergoing Radiotherapy: A Prospective Observational Study.

Authors:  Vikas Gupta; Gunjan Dwivedi; Lokanath Sahoo; Sankalp Singh; Uma Patnaik; Manoj Kumar; Amit Sood
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-06-27

6.  A Study on Prevalence and Determinants of Ototoxicity During Treatment of Childhood Cancer (SOUND): Protocol for a Prospective Study.

Authors:  Franciscus A Diepstraten; Annelot Jm Meijer; Martine van Grotel; Sabine LA Plasschaert; Alexander E Hoetink; Marta Fiocco; Geert O Janssens; Robert J Stokroos; Marry M van den Heuvel-Eibrink
Journal:  JMIR Res Protoc       Date:  2022-04-07

7.  Bacterial brain abscess in patients with nasopharyngeal carcinoma following radiotherapy: microbiology, clinical features and therapeutic outcomes.

Authors:  Peng-Hsiang Fang; Wei-Che Lin; Nai-Wen Tsai; Wen-Neng Chang; Chi-Ren Huang; Hsueh-Wen Chang; Tai-Lin Huang; Hsin-Ching Lin; Yu-Jun Lin; Ben-Chung Cheng; Ben Yu-Jih Su; Chia-Te Kung; Hung-Chen Wang; Cheng-Hsien Lu
Journal:  BMC Infect Dis       Date:  2012-09-03       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.